Aspire began investing in medical cannabis in Florida, where we began to see the need for R&D ranging from operational innovations to medical applications. Since then, Aspire’s core team of investors has expanded to Pennsylvania, Nevada, and is seeking licenses in Georgia, Alabama, and other medical-only states. Wherever we go, Aspire is committed to continuous improvement through our Impact & Innovation Platform. We have established research partnerships in multiple states, which represent an R&D vertical to allow studies from plant genetics, supply-chain, pharmaceutical, and medical perspectives. Our goal is to continuously improve and innovate by applying our discoveries in our own business and beyond. Continuous improvement is not limited to R&D, which takes time – social issues and economic development are areas where Aspire can have an immediate positive impact.